ask="14.05"
ask_size="100"
average_daily_volume="238248"
bid="9.00"
bid_size="200"
book_value="6.06"
change="-0.07"
change_from_200_day_moving_average="-3.10"
change_from_50_day_moving_average="-0.41"
change_from_52_week_high="-17.10"
change_From_52_week_low="1.44"
change_in_percent="-0.52%"
close="13.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.90"
ebitda="-26.00M"
eps_estimate_current_year="-1.20"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="12320000"
high="13.40"
high_52_weeks="30.40"
last_trade_date="2/6/2017"
last_trade_price="13.30"
last_trade_size="2096"
last_trade_time="4:00pm"
low="13.22"
low_52_weeks="11.86"
market_capitalization="478.73M"
moving_average_200_day="16.40"
moving_average_50_day="13.71"
name="Intellia Therapeutics
Inc."
notes="N/A"
one_year_target_price="33.60"
open="13.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-18.89%"
percent_change_from_50_day_moving_average="-3.00%"
percent_change_from_52_week_high="-56.25%"
percent_change_from_52_week_low="+12.09%"
previous_close="13.37"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.21"
price_per_sales="38.36"
revenue="12.55M"
shares_outstanding="35995000"
short_ratio="7.60"
stock_exchange="NGM"
symbol="NTLA"
volume="91272"
weeks_range_52="11.86 - 30.40"
